Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 1997

View Archived Issues

Hair growth stimulants from Tanabe

Nisshin Flour Milling claims antidiabetic compounds

Company Profile: DepoTech Corp.

Novel myocardial protectant described by Taiwanese researchers

Searle describes new platelet aggregation inhibitors

New psychopharmacological agents developed by Ferrer

Novel allergy agent claimed by French researchers

GRF analogues developed for growth hormone deficiencies

COX-2 inhibitors reported by Merck Frosst

Pharmacia & Upjohn claims camptothecin derivatives

Antibacterial and antineoplastic agents developed by Abbott

Thrombin inhibitors from BioChem Pharma

RPR discloses novel polypeptides for cancer

Spotlight on influenza sialidase inhibitors

Novartis selects analgesic agent as clinical candidate

Korean investigators isolate natural antioxidant

Orally active anti-PCP agents developed by U.S. investigators

Enantiospecific synthesis of SP antagonist from RPR

Mediolanum prepares novel quinolone antibacterial agents

NAChR agonist SIB-1765F: Potential antiparkinsonian agent

Spanish pharmaceutical merger confirmed

Hypocholesterolemic activity of raloxifene established in rats

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Preliminary results for potential new anti-HIV combination presented

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Clinical data on AccuSite published in peer-reviewed journals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...